4Pallanti S, Quercioli L, KoranLM. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial [ J ]. J Clin Psychiatry ,2002,63 : 796.
5Kordon A, Wahl K, Koch N, et al. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study [J]. J Clin Psychopharmacol,2008 ,28 :550-554.
6Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder[ J]. Mol Psychiatry ,2006,11 : 622- 632.
7Husted DS, Shapira NA. A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation[ J]. CNS Spectr,2004,9 : 833-847.
8Savas HA, Yumru M, Ozen ME. Quetiapine and ziprasidone as adjuncts in treatment-resistant obsessive-compulsive disorder:a retrospective comparative study [ J ]. Clin Drug Investig, 2008,28 : 439- 442.
9Dell'Osso B, Mundo E, Ahamura AC. Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up case series [ J]. CNS Spectr,2006: 879-883.
10Bog, an AM, Koran LM, Chuong HW, et al. Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors : an open-label study [ J ]. J Clin Psychiatry, 2005,66 : 73 - 79.
